Inside the battle to engineer the perfect anticoagulant for millions
SMRTR summary
Heparin, a widely-used anti-clotting drug, shows potential for treating inflammation, cancer, and Covid-19, with 500 million doses given yearly worldwide and ongoing research to improve production methods and reduce animal-source dependence.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article